The Role of Biospecimens in Advancing Emerging Oncology Modalities
September 14, 2026
The Role of Biospecimens in Advancing Emerging Oncology Modalities

Introduction  The oncology landscape is undergoing a remarkable transformation. Advances in precision medicine, immunotherapy, cell and gene therapies, antibody-drug conjugates (ADCs), and targeted therapies are redefining how cancer is diagnosed, treated, and monitored. These emerging oncology modalities are enabling more personalized treatment approaches, improving patient outcomes, and accelerating the development of innovative therapeutics.  Behind these […]

Read More
Choosing a CRO Partner in India A Practical Evaluation Checklist for Pharma Sponsors
September 8, 2026
Choosing a CRO Partner in India: A Practical Evaluation Checklist for Pharma Sponsors

Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website.  The real problem is different. Sponsors usually know what to look for. What they don’t have […]

Read More